These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17521966)

  • 1. rh-BMP-2 can be used safely in the cervical spine: dose and containment are the keys!
    Dickerman RD; Reynolds AS; Morgan BC; Tompkins J; Cattorini J; Bennett M
    Spine J; 2007; 7(4):508-9. PubMed ID: 17521966
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion.
    Tumialán LM; Rodts GE
    Spine J; 2007; 7(4):509-10. PubMed ID: 17526433
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".
    Bennett M; Reynolds AS; Dickerman RD
    Spine (Phila Pa 1976); 2006 Aug; 31(17):2029-30. PubMed ID: 16924224
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine 2009;34:885-9.
    Cimic M; Smoljanovic T; Bojanic I
    Spine (Phila Pa 1976); 2010 Feb; 35(3):361; author reply 361-2. PubMed ID: 20118766
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone morphogenetic protein.
    Smoljanovic T; Bogovic M; Bojanic I
    J Neurosurg Spine; 2012 Jul; 17(1):98-9; author reply 99. PubMed ID: 22578264
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of prevertebral soft-tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis.
    Stachniak JB; Diebner JD; Brunk ES; Speed SM
    J Neurosurg Spine; 2011 Feb; 14(2):244-9. PubMed ID: 21184639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
    Hiremath GK; Steinmetz MP; Krishnaney AA
    Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.
    Shields LB; Raque GH; Glassman SD; Campbell M; Vitaz T; Harpring J; Shields CB
    Spine (Phila Pa 1976); 2006 Mar; 31(5):542-7. PubMed ID: 16508549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.
    Smucker JD; Rhee JM; Singh K; Yoon ST; Heller JG
    Spine (Phila Pa 1976); 2006 Nov; 31(24):2813-9. PubMed ID: 17108835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.
    Oluigbo CO; Solanki GA
    Pediatr Neurosurg; 2008; 44(5):393-6. PubMed ID: 18703886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study.
    Perri B; Cooper M; Lauryssen C; Anand N
    Spine J; 2007; 7(2):235-9. PubMed ID: 17321975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
    Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
    Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein and fusion.
    Smoljanovic T; Vukicevic S; Pecina M
    J Neurosurg Spine; 2007 Apr; 6(4):378-9; author reply 379-80. PubMed ID: 17436934
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
    Vaidya R; Sethi A; Bartol S; Jacobson M; Coe C; Craig JG
    J Spinal Disord Tech; 2008 Dec; 21(8):557-62. PubMed ID: 19057248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions.
    Smoljanovic T; Bojanic I; Pecina M
    J Spinal Disord Tech; 2009 Jun; 22(4):309; author reply 310. PubMed ID: 19494752
    [No Abstract]   [Full Text] [Related]  

  • 17. Avoiding unanticipated adverse effects of recombinant human bone morphogenetic protein-2 therapy in craniofacial surgery with experiences from spinal applications.
    Smoljanovic T; Janjanin S; Bojanic I
    J Craniofac Surg; 2009 Sep; 20(5):1626. PubMed ID: 19816316
    [No Abstract]   [Full Text] [Related]  

  • 18. Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring.
    Hansen SM; Sasso RC
    J Spinal Disord Tech; 2006 Apr; 19(2):130-4. PubMed ID: 16760788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RE: complications attributable to the use of rhBMP-2 inside the femoral ring allograft during anterior lumbar interbody fusion.
    Smoljanovic T; Pecina M
    Spine J; 2008; 8(2):413-4; author reply 414. PubMed ID: 18178134
    [No Abstract]   [Full Text] [Related]  

  • 20. Transforaminal interbody fusion and the "off label" use of recombinant human bone morphogenetic protein-2.
    Vaidya R
    Spine J; 2009 Aug; 9(8):667-9. PubMed ID: 19622413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.